Lareb Provides Update on Lamotrigine-Associated Alopecia

The document provided an update on the association between lamotrigine, an anticonvulsant medication, and alopecia (hair loss). The update was based on reports collected by Lareb, the Netherlands Pharmacovigilance Centre. It highlighted that there were multiple cases where patients experienced hair loss after starting lamotrigine. The document emphasized the importance of healthcare professionals being aware of this potential side effect to better manage and counsel patients undergoing treatment with lamotrigine.